健康相关生活质量评估在慢性肝病中的应用与进展

肝脏 ›› 2024, Vol. 29 ›› Issue (3): 266-268.

健康相关生活质量评估在慢性肝病中的应用与进展

夏小琦, 杨长青

200065 上海同济大学附属同济医院消化科,同济大学医学院消化疾病研究所

收稿日期:2024-03-03 出版日期:2024-03-31 发布日期:2024-05-16
通讯作者: 杨长青,Email:cqyang@tongji.edu.cn
基金资助:
国家自然科学基金项目 (81820108006,U22A20275);上海市临床重点专科建设项目(SHSLCZDZK 06801);上海申康三年行动计划重大临床研究项目(SHDC2020CR2030B)

Received:2024-03-03 Online:2024-03-31 Published:2024-05-16

摘要/Abstract

摘要： 随着现代医学理念的进步,健康已经不仅仅被定义为没有疾病或弱点,而是身体、心理和社会功能整体良好状态的体现。特别是对于慢性肝病患者而言,他们面临的并发症复杂多变,严重影响生活质量。因此,对这一群体进行健康相关生活质量(HRQOL)的评估变得尤为重要。通过患者报告结局(PRO)的多种方式,例如SF-36、CLDQ、PROMIS-29等, 医护人员能够从患者的视角深入了解他们对于自身疾病状态的主观感受。这种评估不仅帮助医疗团队更好地理解患者的需求,还能指导临床决策,优化治疗方案,从而改善患者的整体健康状态。此外,HRQOL的评估还可以为医疗研究提供重要数据,促进慢性肝病管理方法的创新与发展。

夏小琦, 杨长青. 健康相关生活质量评估在慢性肝病中的应用与进展[J]. 肝脏, 2024, 29(3): 266-268.

参考文献

[1] Marjot T, Ray DW, Williams FR, et al. Sleep and liver disease: a bidirectional relationship. Lancet Gastroenterol Hepatol, 2021,6(10): 850-863.
[2] 白如雪, 杨志云,杜时雨,等. 慢性肝病患者的健康相关生存质量调查分析. 中日友好医院学报,2014, 28(2):77-80.
[3] H?user W, Holtmann G, Grandt D. Determinants of health-related quality of life in patients with chronic liver diseases. Clin Gastroenterol Hepatol,2004,2(2): 157-163.
[4] Udompap P, Kim D, Kim WR. Current and future burden of chronic nonmalignant liver disease.Clin Gastroenterol Hepatol,2015,13(12):2031-2041.
[5] 郑亚彬.慢性肝病住院患者生存质量的影响因素研究. 广西医学, 2018,40(7):788-791.
[6] 贺远龙,刘斌. 健康相关生命质量. 现代诊断与治疗,2004, 15 (6): 362-363.
[7] Kaplan RM, Hays RD. Health-related quality of life measurement in public health. Annu Rev Public Health,2022,43:355-373.
[8] Chang R, Qian X, Xuan Z, et al. Health related quality of life and its impacts by chronic diseases in urban community population, Shanghai, China in 2015. Psychology, Psychol Health Med,2021,26(8):931-939.
[9] Cortesi PA, Conti S, Scalone L, et al. Health related quality of life in chronic liver diseases.Liver Int,2020,40(11):2630-2642.
[10] Bahall M, Bailey H. The impact of chronic disease and accompanying bio-psycho-social factors on health-related quality of life. J Family Med Prim Care,2022 ,11(8):4694-4704.
[11] 隆莉芝,袁玲.患者报告结局的应用近况及思考[J].中国全科医学,2020,23(32):4120-4127.
[12] 曹阳,余小萍.PRO 量表国内外研究近况.中医杂志,2014,55(8):710-714.
[13] 李春波,何燕玲.健康状况调查问卷SF-36的介绍. 国外医学(精神病学分册),2002(2):116-119.
[14] Rajan M, Lai KC, Tseng CL, et al. Estimating utilities for chronic kidney disease, using SF-36 and SF-12-based measures: challenges in a population of veterans with diabetes. Qual Life Res,2013,22(1):53-64.
[15] Sato S, Nishimura K, Tsukino M, et al. Possible Maximal Change in the SF-36 of Outpatients with Chronic Obstructive Pulmonary Disease and Asthma. J Asthma,2004,41(3):355-365.
[16] Younossi ZM, Stepanova M, Noureddin M, et al. Improvements of fibrosis and disease activity are associated with improvement of patient-reported outcomes in patients with advanced fibrosis due to nonalcoholic steatohepatitis. Hepatol Commun,2021,5(7):1201-1211.
[17] Janani K, Jain M, Vargese J, et al. Health-related quality of life in liver cirrhosis patients using SF-36 and CLDQ questionnaires. Clin Exp Hepatol,2018,4(4):232-239.
[18] Chawla KS, Talwalkar JA, Keach JC, et al. Reliability and validity of the Chronic Liver Disease Questionnaire (CLDQ) in adults with non-alcoholic steatohepatitis (NASH). BMJ Open Gastroenterol,2016,3(1):e000069.
[19] Tajiri K, Futsukaichi YH, Murayama A, et al. Chronic liver disease questionnaire to manage patients with chronic liver diseases. Hepatol Res,2022,52(8):712-720.
[20] Les I, Doval E, Flavià M,et al. Quality of life in cirrhosis is related to potentially treatable factors. Eur J Gastroenterol Hepatol, 2010,22(2):221-227.
[21] Yadav D, Askew RL, Palermo T, et al. Association of chronic pancreatitis pain features with physical, mental, and social health. Clin Gastroenterol Hepatol,2023,21(7):1781-1791.e4.
[22] Stanton E, Kowalske K, Won P, et al. Neuropathic Pain After Burn Injury: A Severe and Common Problem in Recovery. Ann Surg,2023.
[23] Lee SJ, Onstad L, Chow EJ, et al.Patient-reported outcomes and health status associated with chronic graft-versus-host disease. Haematologica,2018,103(9):1535-1541.
[24] Desai AP, Madathanapalli A, Tang Q, et al. PROMIS Profile-29 is a valid instrument with distinct advantages over legacy instruments for measuring the quality of life in chronic liver disease. Hepatology,2023,78(6):1788-1799.
[25] Younossi ZM, Stepanova M, Henry L.et al. Performance and validation of Chronic Liver Disease Questionnaire-Hepatitis C Version (CLDQ-HCV) in clinical trials of patients with chronic hepatitis C. Value Health,2016,19(5):544-551.
[26] Younossi ZM, Stepanova M, Younossi I, et al. Validation of chronic liver disease questionnaire for nonalcoholic steatohepatitis in patients with biopsy-proven nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol,2019,17(10):2093-2100.e3.